Insulin degludec (Tresiba): new ultra long-acting basal insulin

Insulin degludec is a new long-acting insulin for use in type 1 and 2 diabetes. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events, and Dr Frank Joseph discusses its place in diabetes treatment compared with other longacting insulins.

Insulin degludec Tresiba new ultra long acting basal insulin

Add yours ↓
Web design and marketing agency Leamington Spa